Zofran and Novantrone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zofran (ondansetron hydrochloride) and Novantrone (mitoxantrone hydrochloride). Common drug interactions include decubitus ulcer among females and lung infection among males.

The phase IV clinical study analyzes what interactions people have when they take Zofran and Novantrone. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.

What is Zofran?

Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. eHealthMe is studying from 94,987 Zofran users. Check the latest studies of Zofran.

What is Novantrone?

Novantrone has active ingredients of mitoxantrone hydrochloride. It is often used in multiple sclerosis. eHealthMe is studying from 3,349 Novantrone users. Check the latest studies of Novantrone.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 20, 2026

48 people who take Zofran and Novantrone together, and have interactions are studied.

Zofran and Novantrone drug interactions.

What are the common drug interactions of Zofran and Novantrone, by gender? *:

female:

  1. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  2. Depression
  3. Hypertension (high blood pressure)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Staphylococcal infection (an infection with staphylococcus bacteria)
  6. Vision blurred
  7. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  8. Partial seizures (seizures which affect only a part of the brain at onset)
  9. Chest pain
  10. Depressed level of consciousness

male:

  1. Lung infection
  2. Rash
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Multi-organ failure (multisystem organ failure)
  5. Death
  6. Confusional state
  7. Decreased appetite
  8. Disease progression
  9. Headache (pain in head)
  10. Pleural effusion (water on the lungs)

What are the common drug interactions of Zofran and Novantrone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anxiety
  2. Asthenia (weakness)
  3. Cardiac failure congestive
  4. Cardiomyopathy (weakening of the heart muscle)
  5. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  6. Depression
  7. Dyspnoea (difficult or laboured respiration)
  8. Hypertension (high blood pressure)
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Staphylococcal infection (an infection with staphylococcus bacteria)

50-59:

  1. Transaminases increased
  2. Cardiac failure congestive
  3. Cardiomegaly (increased size of heart than normal)
  4. Cough
  5. Death
  6. Decreased appetite
  7. Disease progression
  8. Dizziness
  9. Dyspnoea (difficult or laboured respiration)
  10. Dyspnoea at rest (difficult or laboured breathing during rest)

60+:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  3. Dehydration (dryness resulting from the removal of water)
  4. Dyspnoea (difficult or laboured respiration)
  5. Ejection fraction decreased (systolic heart failure)
  6. Acute respiratory failure
  7. Anaemia (lack of blood)
  8. Aspartate aminotransferase increased
  9. Asthenia (weakness)
  10. Atelectasis (partial or complete collapse of the lung)

What are the existing conditions these people have? *

  1. Fatigue (feeling of tiredness): 10 people, 20.83%
  2. Prostate Cancer: 8 people, 16.67%
  3. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 8 people, 16.67%
  4. Psychiatric Symptom: 6 people, 12.50%
  5. Depression: 5 people, 10.42%
  6. Pain: 3 people, 6.25%
  7. Malignant Lymphoid Neoplasm (malignant growth or tumour caused by abnormal and uncontrolled cell division in lymph node): 3 people, 6.25%
  8. Lymphoma (cancer that begins in immune system cells): 3 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Zofran and Novantrone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zofran and Novantrone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zofran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Novantrone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zofran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Novantrone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ondansetron hydrochloride and mitoxantrone hydrochloride (the active ingredients of Zofran and Novantrone, respectively), and Zofran and Novantrone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: